Eagle Pharmaceuticals to Present at November Conferences

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will each present at two conferences in November as follows:

Each presentation will be webcast live at the aforementioned times, and archived for 90 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151112005377/en/

In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President

Source: Eagle Pharmaceuticals, Inc.

You May Also Be Interested In

• Foil Launched AI Platform to Detect Malicious AI Agents and Devices from Manipulating Online Businesses
• FCLGO Launches Amazon Fulfillment Center Locations Routing Service to Eliminate FBA Compliance Rejections for Cross-Border Sellers
• Biotech Labz Supply Offers High Purity Research Peptides Online